Amia Capital as of Dec. 31, 2019
Portfolio Holdings for Amia Capital
Amia Capital holds 41 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Liberty Media Corp Delaware Com A Siriusxm | 21.8 | $75M | 1.5M | 48.34 | |
| iShares JPMorgan USD Emer Mkt Bnd Fd ETF (EMB) | 19.6 | $67M | 586k | 114.56 | |
| Grifols S A Sponsored Adr R (GRFS) | 14.7 | $50M | 2.2M | 23.29 | |
| Liberty Media Corp Delaware Com C Siriusxm | 13.5 | $46M | 962k | 48.14 | |
| BHP Billiton | 5.4 | $18M | 392k | 47.01 | |
| Petroleo Brasileiro SA (PBR) | 3.7 | $13M | 800k | 15.94 | |
| Liberty Latin America (LILA) | 3.4 | $12M | 605k | 19.30 | |
| Vale (VALE) | 3.1 | $11M | 800k | 13.20 | |
| Ionis Pharmaceuticals (IONS) | 1.6 | $5.6M | 93k | 60.41 | |
| iShares NASDAQ Biotechnology Index (IBB) | 1.6 | $5.4M | 44k | 120.50 | |
| Neurocrine Biosciences (NBIX) | 1.1 | $3.7M | 35k | 107.50 | |
| Incyte Corporation (INCY) | 1.0 | $3.5M | 40k | 87.31 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.9 | $3.2M | 14k | 218.93 | |
| iShares MSCI Chile Inv. Mt. Idx (ECH) | 0.9 | $3.0M | 90k | 33.33 | |
| Esperion Therapeutics (ESPR) | 0.7 | $2.4M | 41k | 59.64 | |
| Qiagen Nv | 0.7 | $2.3M | 69k | 34.03 | |
| Alnylam Pharmaceuticals (ALNY) | 0.6 | $2.1M | 18k | 115.18 | |
| Agios Pharmaceuticals (AGIO) | 0.6 | $1.9M | 39k | 47.75 | |
| Alexion Pharmaceuticals | 0.5 | $1.6M | 15k | 108.18 | |
| Argenx Se (ARGX) | 0.5 | $1.6M | 10k | 160.48 | |
| Halozyme Therapeutics (HALO) | 0.5 | $1.6M | 90k | 17.73 | |
| Radius Health | 0.4 | $1.5M | 76k | 20.16 | |
| Lennar Corporation (LEN.B) | 0.4 | $1.4M | 32k | 44.69 | |
| Sage Therapeutics (SAGE) | 0.3 | $1.0M | 14k | 72.22 | |
| Moderna (MRNA) | 0.3 | $1.0M | 53k | 19.56 | |
| Myokardia | 0.3 | $992k | 14k | 72.86 | |
| Intercept Pharmaceuticals In | 0.3 | $951k | 7.7k | 123.86 | |
| Audentes Therapeutics | 0.3 | $910k | 15k | 59.85 | |
| Myovant Sciences | 0.2 | $830k | 54k | 15.51 | |
| Nektar Therapeutics | 0.2 | $583k | 27k | 21.57 | |
| Exelixis (EXEL) | 0.1 | $530k | 30k | 17.61 | |
| Crispr Therapeutics (CRSP) | 0.1 | $513k | 8.4k | 60.88 | |
| Macrogenics (MGNX) | 0.1 | $486k | 45k | 10.89 | |
| Akcea Therapeutics Inc equities | 0.1 | $478k | 28k | 16.94 | |
| Homology Medicines | 0.1 | $426k | 21k | 20.68 | |
| Gilead Sciences (GILD) | 0.1 | $308k | 4.7k | 64.90 | |
| Sangamo Biosciences (SGMO) | 0.1 | $311k | 37k | 8.38 | |
| Ubs Group (UBS) | 0.1 | $325k | 26k | 12.58 | |
| Bristol Myers Squibb (BMY) | 0.1 | $277k | 4.3k | 64.11 | |
| Voyager Therapeutics (VYGR) | 0.1 | $275k | 20k | 13.97 | |
| Wave Life Sciences (WVE) | 0.1 | $165k | 21k | 7.99 |
